ConductScience.org, home
Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine
API referenceFor AI assistants

Trial · NCT02605174

Participant flow35

How many started, completed or left each group, period by period.

1 to 20 of 35

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDLasmiditan 50 Milligram (mg)/Lasmiditan 50 mg501
Overall StudySTARTEDLasmiditan 50 mg/Placebo249
Overall StudySTARTEDLasmiditan 100 mg/Lasmiditan 100 mg502
Overall StudySTARTEDLasmitidan 100 mg/Placebo252
Overall StudySTARTEDLasmiditan 200 mg/Lasmiditan 200 mg501
Overall StudySTARTEDLasmitidan 200 mg/Placebo249
Overall StudySTARTEDPlacebo/Placebo751
Overall StudyReceived at Least 1 Dose of Study DrugLasmiditan 50 Milligram (mg)/Lasmiditan 50 mg429
Overall StudyReceived at Least 1 Dose of Study DrugLasmiditan 50 mg/Placebo225
Overall StudyReceived at Least 1 Dose of Study DrugLasmiditan 100 mg/Lasmiditan 100 mg423
Overall StudyReceived at Least 1 Dose of Study DrugLasmitidan 100 mg/Placebo212
Overall StudyReceived at Least 1 Dose of Study DrugLasmiditan 200 mg/Lasmiditan 200 mg434
Overall StudyReceived at Least 1 Dose of Study DrugLasmitidan 200 mg/Placebo215
Overall StudyReceived at Least 1 Dose of Study DrugPlacebo/Placebo645
Overall StudyReceived Optional 2nd DoseLasmiditan 50 Milligram (mg)/Lasmiditan 50 mg206
Overall StudyReceived Optional 2nd DoseLasmiditan 50 mg/Placebo96
Overall StudyReceived Optional 2nd DoseLasmiditan 100 mg/Lasmiditan 100 mg177
Overall StudyReceived Optional 2nd DoseLasmitidan 100 mg/Placebo83
Overall StudyReceived Optional 2nd DoseLasmiditan 200 mg/Lasmiditan 200 mg144
Overall StudyReceived Optional 2nd DoseLasmitidan 200 mg/Placebo74

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02605174/flow

API referenceFor AI assistants